Analysts' recommendations : Carmat SA

25-05-09	Carmat: Invest Securities raises target price
25-04-11	Carmat: Invest Securities still a buyer, but cuts TP
25-02-04	Carmat: Invest Securities slightly lowers its target
25-01-09	Carmat: Invest Securities upgrades to buy
25-01-09	Carmat: Oddo BHF reduces its price target

More recommendations

News in other languages : Carmat SA

Mar. 04	Carmat, Ynsect… quand les pépites industrielles françaises tombent dans le gouffre de Moore
Jan. 07	Pluxee N : Carmat, Hoffmann, LDC, Pluxee, Technip Energies... les valeurs à suivre aujourd'hui à Paris
Jan. 07	Bourse : GTT et Technip Energy engrangent, Pluxee publie, Carmat disparaît
Jan. 07	CARMAT : A suivre aujourd'hui
Jan. 07	Les records continuent à tomber en bourse

More news

Managers and Directors : Carmat SA

Manager	Title	Age	Since
Stéphane Piat CEO	Chief Executive Officer	55	2016-08-31
Pascale d’Arbonneau DFI	Director of Finance/CFO	-	2018-12-11
Christian Latrémouille CTO	Chief Tech/Sci/R&D Officer	-	2025-03-31

Director	Title	Age	Since
Stéphane Piat BRD	Director/Board Member	55	-
Jean-Luc Lemercier BRD	Director/Board Member	68	2017-01-01
Michael Mack BRD	Director/Board Member	79	2017-04-19

More insiders

Carmat SA, formerly known as Carmat SAS is a France-based company engaged in the development and production of heart prosthesis. The Company is developing an orthotopic and biocompatible artificial heart which works like a natural heart, and which is hydraulically activated. It specializes in the development of a fully implantable orthotopic artificial heart, its electrical power supply system, and its telediagnosis system. The Company formed a network of partnerships with hospitals and various scientific companies, such as The Georges Pompidou European Hospital, The Marie Lannelongue Surgical Center, The Hospital Charles Nicolle of Rouen, Dedienne Sante, PaxiTech, Vignal Artru Industries, French Vessels, and Blood Institute, Laboratoire de Recherche Biochirurgicale and others.

Employees

153

Sector

Medical Equipment, Supplies & Distribution

More about the company

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

Market Closed - Euronext Paris 2026-03-20			5-day change	1st Jan Change
0.0990 ^EUR	-.--%		-.--%	-

Sep. 01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris

Market Cap	6.15M 7.14M 5.77M 5.28M 9.85M 675M 9.93M 68.23M 26.57M 345M 26.82M 26.24M 1.11B	P/E 2023	-3.09x	P/E 2024	-0.95x
Enterprise Value	59.25M 68.86M 55.6M 50.87M 94.94M 6.51B 95.69M 658M 256M 3.33B 259M 253M 10.71B	EV / Sales 2023	56.1x	EV / Sales 2024	13.5x
Free-Float	89.06%	Yield 2023 *	-	Yield 2024	-

Sep. 01	CARMAT SAS Publishes Results Of EFICAS Clinical Study On Aeson Total Artificial Heart As Bridge-To-Transplant Therapy	CI
Jan. 07	Carmat, Hoffmann, LDC, Pluxee, Technip Energies... Stocks to Watch Today in Paris
Jan. 07	CARMAT: To Watch Today
Jan. 06	Carmat, GTT, Genfit, LDC... Stocks to Watch Tomorrow in Paris
Jan. 06	Carmat Announces Liquidation and Delisting
Dec. 02	Only Takeover Bid for Carmat Approved by Court
Dec. 02	Carmat: Takeover Offer Approved, 88 Jobs Saved	RE
Dec. 02	Carmat receives takeover bid	RE
Nov. 04	Carmat SAS submits bid for Carmat SA within ongoing receivership procedure	RE
25-10-15	CAC 40 Surges on LVMH Results and Easing US-China Tensions
25-10-15	Carmat: Judicial Recovery Continues, New Hearing Set for November 25	RE
25-10-15	Carmat says liquidation review postponed until Nov 25	RE
25-10-01	Carmat: Judicial Liquidation Request to Be Reviewed on October 14	RE

Dec. 02	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
Nov. 04	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU
25-10-29	CARMAT : Inside Information / Other news releases	PU
25-10-29	CARMAT Announces Postponing the Publication of its 2025 Interim Financial Report (Six Months Ended June 30, 2025)	BU
25-10-15	CARMAT Provides an Update on the Ongoing Receivership Procedure	BU

Carmat SA Stock

Stocks

ALCAR

FR0010907956

Medical Equipment, Supplies & Distribution

Valuation : Carmat SA

Chart: Carmat SA

Latest news : Carmat SA

Analysts' recommendations : Carmat SA

Press Releases : Carmat SA

News in other languages : Carmat SA

Price Extremes

Managers and Directors : Carmat SA

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Current year	0.1	0.1
1 year	0.1	0.16
3 years	0.08	9.99
5 years	0.08	31.7
10 years	0.08	41.54

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/13/25	Pierre Bastid	Sell	Chairman	1,343,333	2.3347%
3/13/25	Pierre Bastid	Buy	Chairman	1,343,333	2.3347%
5/29/24	Antonino Ligresti	Buy	Director	1,343,333	4.6122%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
CARMAT SA	-.--%	-.--%	-18.99%	-98.55%	7.08M
STRYKER CORPORATION	-0.81%	-4.04%	-20.44%	+7.97%	120B
SMITH & NEPHEW PLC	-0.99%	-1.91%	-24.26%	-0.28%	12.07B
GLAUKOS CORPORATION	+0.73%	-0.83%	+90.95%	+145.17%	10.58B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.67%	-2.76%	-52.33%	-70.90%	4.16B
DOUBLE MEDICAL TECHNOLOGY INC.	+0.91%	-10.65%	-24.45%	+36.04%	2.46B
INSIGHT LIFETECH CO., LTD.	-1.48%	-2.27%	-	-	1.98B
INSPIRE MEDICAL SYSTEMS, INC.	-0.94%	+2.73%	-27.01%	-73.33%	1.82B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-2.56%	-6.12%	-19.96%	-25.12%	1.56B
Average	-0.77%	-2.89%	-12.06%	-9.88%	17.15B
Weighted average by Cap.	-0.84%	-4.52%	-14.02%	+13.83%

	2023	2024
Net sales	3.84M 4.46M 3.6M 3.29M 6.15M 422M 6.2M 42.6M 16.59M 215M 16.75M 16.38M 694M	7.34M 8.54M 6.89M 6.31M 11.77M 807M 11.86M 81.53M 31.75M 412M 32.05M 31.35M 1.33B
Net income	-53.87M -62.61M -50.55M -46.25M -86.32M -5.92B -87.01M -598M -233M -3.02B -235M -230M -9.74B	-51.4M -59.73M -48.23M -44.13M -82.36M -5.65B -83.01M -571M -222M -2.89B -224M -219M -9.29B
Net Debt	49.64M 57.69M 46.58M 42.62M 79.54M 5.45B 80.17M 551M 215M 2.79B 217M 212M 8.98B	53.1M 61.72M 49.83M 45.59M 85.09M 5.83B 85.77M 589M 230M 2.98B 232M 227M 9.6B